Total Payments
$28,446
2024 Payments
$15.27
Companies
6
Transactions
52
Medicare Patients
2,906
Medicare Billing
$302,536
Payment Breakdown by Category
Other$25,958 (91.3%)
Food & Beverage$1,579 (5.6%)
Travel$693.90 (2.4%)
Education$215.25 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,958 | 12 | 91.3% |
| Food and Beverage | $1,579 | 33 | 5.6% |
| Travel and Lodging | $693.90 | 4 | 2.4% |
| Education | $215.25 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $17,989 | 31 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $10,120 | 12 | $0 (2018) |
| Janssen Biotech, Inc. | $248.41 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $57.87 | 3 | $0 (2020) |
| Smith+Nephew, Inc. | $16.17 | 1 | $0 (2023) |
| PFIZER INC. | $15.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.27 | 1 | PFIZER INC. ($15.27) |
| 2023 | $16.17 | 1 | Smith+Nephew, Inc. ($16.17) |
| 2022 | $113.66 | 2 | Janssen Biotech, Inc. ($113.66) |
| 2020 | $245.46 | 7 | Janssen Biotech, Inc. ($134.75) |
| 2019 | $45.36 | 2 | GENZYME CORPORATION ($23.03) |
| 2018 | $17,437 | 24 | GENZYME CORPORATION ($13,460) |
| 2017 | $10,574 | 15 | Regeneron Healthcare Solutions, Inc. ($6,143) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 11/17/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Other Advanced Wound Management | ||||||
| 05/03/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Immunology | ||||||
| 04/26/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 09/02/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/27/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 05/05/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Immunology | ||||||
| 04/07/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Immunology | ||||||
| 03/16/2020 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 02/20/2020 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Immunology | ||||||
| 01/30/2020 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Immunology | ||||||
| 03/06/2019 | GENZYME CORPORATION | DUPIXENT (Drug), DERMATITIS - DISEASE | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 02/25/2019 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $417.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/30/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,128.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $102.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2018 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $16.33 | General |
| 10/19/2018 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $22.65 | General |
| 10/03/2018 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $21.86 | General |
| 09/28/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $834.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2018 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $24.09 | General |
| 07/20/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,189.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $115.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2018 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $18.49 | General |
| 05/16/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,189.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 445 | 477 | $167,938 | $48,193 |
| 2022 | 11 | 621 | 669 | $169,785 | $42,764 |
| 2021 | 16 | 1,007 | 1,264 | $432,356 | $128,528 |
| 2020 | 13 | 833 | 979 | $293,177 | $83,052 |
Total Patients
2,906
Total Services
3,389
Medicare Billing
$302,536
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $29,664 | $10,160 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $24,112 | $7,905 | 32.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 65 | 68 | $49,164 | $7,774 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 70 | $19,180 | $7,494 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 63 | $11,844 | $5,281 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $12,444 | $5,141 | 41.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 26 | 27 | $15,525 | $2,633 | 17.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 30 | 31 | $4,805 | $1,655 | 34.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 17 | 24 | $1,200 | $150.50 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 240 | $64,395 | $17,091 | 26.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 41 | 43 | $19,017 | $4,717 | 24.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 50 | 54 | $17,542 | $4,652 | 26.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 90 | 93 | $18,445 | $4,482 | 24.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 21 | $15,789 | $3,952 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 60 | 65 | $11,700 | $2,740 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $10,072 | $1,787 | 17.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $3,667 | $1,162 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $5,445 | $1,036 | 19.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 11 | 15 | $2,275 | $727.66 | 32.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 54 | 74 | $1,438 | $417.01 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 300 | 370 | $140,447 | $42,283 | 30.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 118 | 140 | $44,046 | $13,263 | 30.1% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 20 | 22 | $44,855 | $12,600 | 28.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $27,171 | $8,496 | 31.3% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 60 | 63 | $24,994 | $7,851 | 31.4% |
About Dr. Daniel Buchen, MD
Dr. Daniel Buchen, MD is a MOHS-Micrographic Surgery healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922069467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Buchen, MD has received a total of $28,446 in payments from pharmaceutical and medical device companies, with $15.27 received in 2024. These payments were reported across 52 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,958).
As a Medicare-enrolled provider, Buchen has provided services to 2,906 Medicare beneficiaries, totaling 3,389 services with total Medicare billing of $302,536. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatopathology, Pediatric Dermatology
- Location Staten Island, NY
- Active Since 03/31/2006
- Last Updated 09/09/2019
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1922069467
Products in Payments
- DUPIXENT (Drug) $13,344
- DUPIXENT DUPILUMAB INJECTION (Biological) $10,120
- ATOPIC DERMATITIS - DISEASE (Drug) $4,393
- TREMFYA (Drug) $248.41
- DERMATITIS - DISEASE (Drug) $198.72
- DUPIXENT (Biological) $110.71
- GRAFIX PL (Medical Supply) $16.17
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.